Ivabradine as a heart rate-lowering agent in a patient with end-stage renal failure after heart transplantation

Kardiologia Polska

Volumn 68, Issue 6, 2010, Pages 684-686

  Kurpesa, Maøgorzata ^a   Trzos, Ewa ^a   Wierzbowska Drabik, Karina ^a   Rechciński, Tomasz ^a  

^a Medical University of Lodz Bieganski Hospital   (Poland)

Author keywords

Heart transplantation; Ivabradine; Renal failure

Indexed keywords

ACETYLSALICYLIC ACID; ALBUMIN; AMINOTRANSFERASE; AMLODIPINE; BILIRUBIN; CREATININE; CYCLOSPORIN; IVABRADINE; METOPROLOL; POTASSIUM; SIMVASTATIN; VALSARTAN;

ADULT; ALBUMIN BLOOD LEVEL; AMINOTRANSFERASE BLOOD LEVEL; ANGIOCARDIOGRAPHY; ANKLE EDEMA; ARTICLE; BILIRUBIN BLOOD LEVEL; BLOOD PRESSURE; CARDIOPULMONARY EXERCISE TEST; CASE REPORT; CHRONIC OBSTRUCTIVE LUNG DISEASE; CREATININE BLOOD LEVEL; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DYSPNEA; ELECTROCARDIOGRAM; EXERCISE; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE OVERLOAD; HEART PALPITATION; HEART RATE; HEART RIGHT BUNDLE BRANCH BLOCK; HEART TRANSPLANTATION; HEMODIALYSIS; HOLTER MONITORING; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; HYPERTENSION; KIDNEY FAILURE; POTASSIUM BLOOD LEVEL; SINUS RHYTHM; SMOKING; THORAX PAIN; UREA BLOOD LEVEL;

EID: 77953742937     PISSN: 00229032     EISSN: 00229032     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Diaz A, Bourassa MG, Guertin MC et al. Long-term prognostic value of resting heart rate in patients with suspected or proven coronary artery disease. Eur Heart J, 2005; 26: 967-974. (Pubitemid 40695027)
2. Scott CD, McComb JM, Dark JH. Heart rate and late mortality in cardiac transplant recipients. Eur Heart J, 1993; 14: 530-533.
3. Berdeaux A. Preclinical results with If current inhibition by ivabradine. Drugs, 2007; 67 (suppl. 2): 25-33.
4. Tardif JC. Clinical results of I(f) current inhibition by ivabradine. Drugs, 2007; 67 (suppl. 2): 35-41. (Pubitemid 350119762)
5. Fox K, Ford I, Steq PG et al. BEAUTIFUL Investigators. Ivabradine for patients with stable coronary artery disease and left ventricular systolic dysfunction (BEAUTIFUL): a randomized, double-blind, placebo-controlled trial. Lancet, 2008; 372: 807-816.
6. Doesch AO, Celic S, Ehlermann P et al. Heart rate reduction after heart transplantation with beta-blocker versus the selective If channel anatgonist ivabradine. Transplantation, 2007; 84: 988-996. (Pubitemid 350301044)
7. Zhang R, Haverich A, Strüber M et al. Effects of ivabradine on allograft function and exercise performance in heart transplant recipients with permanent sinus tachycardia. Clin Res Cardiol, 2008; 97: 811-819.
8. Myers BD, Newton L. Cyclosporine-induced chronic nephropathy: an obliterative microvascular renal injury. J Am Soc Nephrol, 1991; 2: S45-S52.
9. Frimat L, Villemot JP, Cormier L et al. Treatment of end-stage renal failure after heart tranplantation. Nephrol Dial Transplant, 1998; 13: 2905-2908. (Pubitemid 28479543)
10. Drouin A, Gendron ME, Thorin E et al. Chronic heart rate reduction by ivabradine prevents endothelial dysfunction in dyslipidemic mice. Br J Pharmacol, 2008; 154: 749-757. (Pubitemid 351821579)